Back to News

Categories: News | Published On: August 23, 2022 | Written by Brandon Tilley |

The Logical Song: Biolojic Design Reimagines Antibodies into “Smart” Therapeutics

Back to News
More News
  • Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024
    Read More
  • Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany.
    Read More
BUSINESS AND MEDIA INQUIRIES

Micah Pearlman
micah@biolojic.com